According to a publication from OncLive, the FDA has granted TG Therapeutics' experimental marginal zone lymphoma drug Umbralisib a "Breakthrough Therapy" designation. About Marginal Zone Lymphoma Marginal zone lymphoma (or…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
